Apple (NSDQ:AAPL) is reportedly conducting internal research into whether its iPhone and Apple Watch could be used to monitor drug dosage and wellness data for patients suffering from Parkinson’s disease. The company hopes to show the effectiveness of mobile monitoring, sources told Fast Company. Patients who suffer from Parkinson’s disease may only visit their doctor at 6-month intervals, which […]
Roche
Trump’s win boosts drug stocks
Pharmaceutical stocks surged today after Donald Trump won the U.S. presidential election, as investors concluded the threat of action on drug pricing had lessened. California’s Proposition 61, which would have prevented the state of California from purchasing drugs from a manufacturer for a price higher than that paid by the U.S. Veterans Affairs Dept., failed to […]
FDA approves Genentech’s Lucentis pre-filled ranibizumab syringe
Genentech, a member of the Roche group (PINK:RHHBY), said today that it won FDA clearance for its Lucentis (ranibizumab injection) pre-filled syringes. The anti-VEGF medicine is FDA-approved to treat wet age-related macular degeneration and macular edema after retinal vein occlusion. The pre-filled syringe enables physicians to eliminate steps in preparation and administration process, the company […]
